Bioblast pharma ltd. (ENLV)
Balance Sheet / Yearly
Dec'17Dec'16Dec'15Dec'14Dec'13
Assets
CURRENT ASSETS:
Cash and cash equivalents

3,526

6,871

7,286

10,583

270

Short-term bank deposits

0

3,007

12,046

22,028

0

Receivables and prepaid expenses

96

663

1,060

274

29

Total current assets

3,622

10,541

20,392

32,885

299

LONG TERM ASSETS:
Long-term assets

0

18

33

9

5

Property and equipment, net

0

71

91

60

2

Total long-term assets

0

89

124

69

7

Total Assets

3,622

10,630

20,516

32,954

306

Liabilities and shareholders Equity
CURRENT LIABILITIES
Trade payables

19

700

1,412

1,285

46

Other accounts payable

441

1,231

1,102

995

85

Total current liabilities

460

1,931

2,514

2,280

131

LONG-TERM LIABILITIES

-

-

70

0

-

Shareholders equity:
Ordinary shares of NIS 0.05 par value - 10,000,000 shares authorized at December 31, 2017 and 2016; 3,342,393 issued and outstanding shares at December 31, 2017 and 3,278,487 issued and outstanding shares at December 31, 2016, respectively

45

45

39

39

24

Additional paid-in capital

48,871

48,463

41,680

39,057

1,551

Accumulated deficit

-45,754

-39,809

-23,787

-8,422

-1,400

Total shareholders equity

3,162

8,699

17,932

30,674

175

Total liabilities and shareholders equity

3,622

10,630

20,516

32,954

306